Get the Stockscreener App
89.56
0.20%
-0.20
Vaneck Pharmaceutical Etf stock is traded at $89.56, with a volume of 166.30K.
It is down -0.20% in the last 24 hours and up +2.89% over the past month.
See More
Previous Close:
$89.76
Open:
$89.94
24h Volume:
166.30K
Relative Volume:
0.73
Market Cap:
$907.13M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.74%
1M Performance:
+2.89%
6M Performance:
-2.12%
1Y Performance:
+2.10%
1-Day Range:
$89.48
$90.08
1-Week Range:
$87.76
$90.65
52-Week Range:
$84.48
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Name
Vaneck Pharmaceutical Etf
Sector
Industry
Phone
-
Address
-
Compare PPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
89.57 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
298.81 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
602.37 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
605.29 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
247.96 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
524.84 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Stock (PPH) Latest News
Is Wall Street Bullish or Bearish on AbbVie Stock? - Inkl
JPMorgan Chase & Co. Has $907,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Barclays PLC Sells 3,263 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - MSN
Is Investing in the WisdomTree Cloud Computing ETF (WCLD) a Smart Move - espeaks.co.uk
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
Is Investing in the Invesco Semiconductors ETF (PSI) a Smart Move - espeaks.co.uk
What Trump's Presidency Will Mean for Bitcoin - VanEck
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Canada Finance
Annual ETF Highlights: A Dive Into the Best and Worst of 2024 - VanEck
Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Barchart
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
Taking a Look Under the Hood of VanEck’s Video Gaming and Esports Strategy - VanEck
Sanctuary Advisors LLC Sells 41,736 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Jane Street Group LLC - Defense World
Stifel Financial Corp Has $742,000 Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
MML Investors Services LLC Decreases Position in Five Below, Inc. (NASDAQ:FIVE) - Defense World
MML Investors Services LLC Has $362,000 Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
VanEck Mortgage REIT Income ETF (NYSEARCA:MORT) Shares Sold by Stifel Financial Corp - Defense World
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
Broad Market Gains Shape Moat Strategies for 2025 - VanEck
Fmr LLC Buys 212 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
PPH Is a Pertinent Healthcare Idea for 2025 - ETF Trends
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - MSN
Bank of Montreal Can Grows Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
The Inflation Reduction Act: A Green Catalyst - VanEck
Winners And Losers: Post-Election Options Analysis - Barchart
A Better Way to Equal Weight? - VanEck
Big Pharma earnings season in spotlight amid positive sentiment - MSN
Investment Opportunities in SMRs: The Future of Nuclear Power - VanEck
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink? - MSN
October Gold Rally and Key Earnings Insights - VanEck
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Strong Trading Volume – Time to Buy? - Defense World
US Bancorp DE Cuts Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
The U.S. Shakes Up Global Pharma Supply Chains - Seeking Alpha
Trading The Shit Show: November 2024 Market Review - substack.com
AbbVie shares slip after schizophrenia drug trial misses primary endpoint - MSN
Health Care Roundup: Market Talk - MSN
RAPT scraps zelnecirnon program, stock plunges 44% - MSN
JPMorgan BetaBuilders U.S. Treasury Bond 20+ Year ETF declares monthly distribution of $0.3949 - MSN
Invesco BulletShares 2028 Municipal Bond ETF declares monthly distribution of $0.0567 - MSN
5 Biggest Pharmaceutical ETFs in 2024 - Investing News Network
Stocks And ETFs In Focus As Americans Head To Polls - Barchart
From Gold to Digital Gold: VanEck's Journey with Crypto - VanEck
Vaneck Pharmaceutical Etf Stock (PPH) Financials Data
There is no financial data for Vaneck Pharmaceutical Etf (PPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):